Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.77 [0.67-0.88],0.000154165204009116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH15,Cadherin-15,Inverse variance weighted,18,0.75 [0.64-0.87],0.000160204444991754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1.28 [1.12-1.45],0.00027965971103048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1.18 [1.06-1.32],0.00228980908217405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.08 [1.03-1.14],0.00303615829014942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NFASC,Neurofascin,Inverse variance weighted,15,0.82 [0.72-0.94],0.00484529389469872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.58 [0.4-0.85],0.0056431695717637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.61 [1.13-2.27],0.00766504766594453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.82 [0.7-0.95],0.00778904361234124,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.15 [0.04-0.63],0.00896298080275087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,37,0.88 [0.8-0.97],0.00990324299940754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,1.07 [1.02-1.12],0.00994952359074477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.67 [0.5-0.91],0.010199271067731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.27 [1.06-1.53],0.0106018204173224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.32 [1.06-1.65],0.0116788083571764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1.25 [1.05-1.5],0.0133022848229279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.85 [0.74-0.97],0.0147039870916311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.46 [0.25-0.86],0.0150199581473102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.86 [1.12-3.11],0.0174329202091648,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.21 [1.03-1.43],0.0176185121203219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.1 [1.02-1.19],0.0178623461108314,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSL,Cathepsin L1,Wald ratio,1,4.25 [1.28-14.16],0.0183641448429862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.76 [0.6-0.96],0.0239335268683807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OGN,Mimecan,Inverse variance weighted,30,1.14 [1.02-1.27],0.0254160585650937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GRN,Progranulin,Inverse variance weighted,7,1.23 [1.02-1.46],0.0258868522050877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.78 [1.06-2.99],0.0279121631518269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.08 [1.01-1.15],0.0296254841849756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.72 [0.54-0.97],0.0318571904696301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.12 [1.01-1.25],0.0319975003304092,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,3.98 [1.1-14.31],0.0346387502440413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.1 [1.01-1.21],0.0346407639914123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DRAXIN,Draxin,Inverse variance weighted,13,1.16 [1.01-1.33],0.0349613948182126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.57 [1.03-2.39],0.0368863347975311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA4,Carbonic anhydrase 4,Inverse variance weighted,12,1.14 [1.01-1.29],0.0372164261578242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLK4,Kallikrein-4,Inverse variance weighted,17,0.88 [0.78-0.99],0.0379929008074049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,0.79 [0.63-0.99],0.0383819859900714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.8 [0.65-0.99],0.0384640713460121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANG,Angiogenin,Inverse variance weighted,19,0.88 [0.79-0.99],0.0391160716691168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.12 [1.01-1.25],0.0399866197953624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,16,1.13 [1-1.28],0.0413934114091576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.14 [1-1.29],0.0456572759953058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.8 [0.65-1],0.0465751706505826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.81 [0.65-1],0.0479898669103686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,XCL1,Lymphotactin,Inverse variance weighted,31,0.92 [0.84-1],0.0487991474891809,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.39 [1-1.94],0.0522933804949092,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SERPINB8,Serpin B8,Inverse variance weighted,28,0.94 [0.88-1],0.0526566994795969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.21 [1-1.48],0.0540306054730814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.5 [0.99-2.27],0.0559442678028641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS3,Galectin-3,Inverse variance weighted,25,0.9 [0.8-1.01],0.0613595051766476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA3,Carbonic anhydrase 3,Inverse variance weighted,6,0.73 [0.52-1.02],0.0627866809809915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXCL8,Interleukin-8,Inverse variance weighted,6,1.51 [0.98-2.32],0.0641466649649761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.66 [0.42-1.03],0.0650619487160229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.09 [0.99-1.2],0.0651576922520305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.89 [0.79-1.01],0.0656279726248076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.86 [0.74-1.01],0.0658068099456267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.89 [0.78-1.01],0.0658977018574972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.72 [0.5-1.03],0.0701456602207874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,0.95 [0.89-1.01],0.0774870855291796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP3,Stromelysin-1,Inverse variance weighted,34,0.87 [0.75-1.02],0.0799124256886572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,1.94 [0.92-4.1],0.0805144903006469,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.17 [0.98-1.4],0.0820992108287533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.92 [0.84-1.01],0.0835411110872584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CX3CL1,Fractalkine,Inverse variance weighted,9,1.25 [0.97-1.6],0.0853604074795381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.3 [0.96-1.75],0.0867332467054741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,1.11 [0.98-1.26],0.0893033330747187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.08 [0.99-1.17],0.0895831602363315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,3.04 [0.84-10.95],0.0898992258431836,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.07 [0.99-1.16],0.0905149041748687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,3.5 [0.82-14.97],0.0908121386817089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD70,CD70 antigen,Inverse variance weighted,28,0.93 [0.85-1.01],0.0937782866079542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,0.88 [0.76-1.02],0.0967741313305847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.3 [0.95-1.77],0.0987706831094369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,0.74 [0.52-1.06],0.101967812608185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.14 [0.97-1.33],0.102106572989507,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GUCA2A,Guanylin,Inverse variance weighted,9,1.24 [0.96-1.6],0.104785315663358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANXA10,Annexin A10,Wald ratio,1,2.46 [0.83-7.3],0.105540830468395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PYY,Peptide YY,Inverse variance weighted,6,1.2 [0.96-1.49],0.106243925538485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.76 [0.54-1.06],0.106689799035253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PKD1,Polycystin-1,Inverse variance weighted,12,0.83 [0.67-1.04],0.107381763096259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.86 [0.72-1.03],0.108292512567539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.14 [0.97-1.35],0.10918821257955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.15 [0.97-1.35],0.110681810118349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.17 [0.96-1.43],0.111196759449546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FBLN2,Fibulin-2,Inverse variance weighted,11,1.12 [0.97-1.3],0.112588981332655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.77 [0.56-1.06],0.113199288869339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.84 [0.68-1.04],0.113487246576547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.85 [0.69-1.04],0.113734953360097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.23 [0.95-1.6],0.114808787263261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.22 [0.95-1.58],0.122085044437809,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.69 [0.43-1.1],0.122804817043682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,0.86 [0.71-1.04],0.123127777818768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,0.84 [0.67-1.05],0.123369160529457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REN,Renin,Inverse variance weighted,4,1.17 [0.96-1.42],0.125601259550071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.24 [0.94-1.62],0.129387389127741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.05 [0.99-1.11],0.130678620122021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.93 [0.85-1.02],0.135564229726538,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DSG2,Desmoglein-2,Inverse variance weighted,11,1.15 [0.96-1.38],0.135950804941136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,C7,Complement component C7,Inverse variance weighted,38,1.05 [0.98-1.12],0.137808833690443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,0.78 [0.57-1.09],0.142440539605188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,UMOD,Uromodulin,Inverse variance weighted,29,0.94 [0.86-1.02],0.144220721029255,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.12 [0.96-1.31],0.146015631477026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OLFM4,Olfactomedin-4,Inverse variance weighted,37,1.07 [0.98-1.16],0.146229344868191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1.1 [0.97-1.25],0.147867537116552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,0.93 [0.84-1.03],0.1492720459694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.63 [0.84-3.17],0.150524806679753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.13 [0.96-1.33],0.152781736910493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.76 [0.52-1.11],0.152808588367645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.78 [0.55-1.1],0.153312203223257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.12 [0.96-1.31],0.155067253809179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.56 [0.84-2.88],0.156922769672218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,0.76 [0.53-1.11],0.157272597144734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.65 [0.36-1.18],0.15733150607565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH1,Cadherin-1,Wald ratio,1,2.35 [0.71-7.73],0.160997823489339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.19 [0.93-1.52],0.161529744275792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,1.24 [0.92-1.67],0.163592729749924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,0.95 [0.87-1.02],0.164727647631164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS1,Galectin-1,Inverse variance weighted,6,0.87 [0.71-1.06],0.171421435759319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.06 [0.97-1.16],0.172078372383782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VWC2,Brorin,Inverse variance weighted,22,0.91 [0.79-1.04],0.175907185490705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,14,1.11 [0.95-1.29],0.176583613560038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.07 [0.97-1.18],0.178480028707013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAYN,Layilin,Inverse variance weighted,20,1.13 [0.95-1.34],0.178497012183708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.05 [0.98-1.12],0.180510727572101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHAD,Chondroadherin,Inverse variance weighted,3,1.12 [0.95-1.33],0.182143181704108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD48,CD48 antigen,Inverse variance weighted,18,1.08 [0.96-1.21],0.183434376844998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.93 [0.83-1.04],0.184629974985187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PVR,Poliovirus receptor,Inverse variance weighted,27,1.05 [0.98-1.14],0.187336837618799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SEPTIN8,Septin-8,Inverse variance weighted,2,1.3 [0.88-1.93],0.189264287161346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MFGE8,Lactadherin,Inverse variance weighted,11,1.11 [0.95-1.31],0.193059828692101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.09 [0.96-1.24],0.19703759130539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AGRN,Agrin,Inverse variance weighted,17,0.9 [0.76-1.06],0.197836887121792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.79 [0.55-1.13],0.200475347690471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RSPO1,R-spondin-1,Inverse variance weighted,5,0.86 [0.69-1.08],0.202042906487931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1.1 [0.95-1.27],0.203015587585585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PSAP,Prosaposin,Inverse variance weighted,5,0.85 [0.67-1.09],0.203254311412197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.9 [0.77-1.06],0.205133186432833,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH17,Cadherin-17,Inverse variance weighted,14,0.9 [0.76-1.06],0.210093947225484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.85 [0.66-1.1],0.212158842888068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,1.95 [0.68-5.58],0.213517600966339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,4,0.86 [0.67-1.09],0.214030990244706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,19,1.08 [0.96-1.22],0.219773013045899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MDK,Midkine,Inverse variance weighted,4,1.26 [0.87-1.81],0.219916273896799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NECTIN2,Nectin-2,Inverse variance weighted,5,0.86 [0.67-1.1],0.222028087183848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.23 [0.88-1.72],0.226050957088329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCN5,CCN family member 5,Inverse variance weighted,8,0.77 [0.5-1.18],0.226534062578376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.61 [0.74-3.51],0.228379227045184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.84 [0.64-1.11],0.232036172994068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.69 [0.37-1.27],0.232886816590735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.94 [0.85-1.04],0.236302148888735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD276,CD276 antigen,Inverse variance weighted,20,1.06 [0.96-1.16],0.239041221687265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MUC13,Mucin-13,Inverse variance weighted,9,1.14 [0.92-1.42],0.241533705568934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSO,Cathepsin O,Inverse variance weighted,6,1.16 [0.9-1.5],0.242142366626749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPON1,Spondin-1,Inverse variance weighted,21,1.09 [0.95-1.25],0.24216084289589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.06 [0.96-1.17],0.242712899376008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,0.95 [0.86-1.04],0.24352364475575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,2.03 [0.62-6.67],0.245120123764545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,0.85 [0.65-1.12],0.247323627705751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,0.87 [0.69-1.1],0.247531711927741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CALB1,Calbindin,Inverse variance weighted,2,0.69 [0.36-1.3],0.248336095176937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VTCN1,V-set domain-containing T-cell activation inhibitor 1,Wald ratio,1,0.59 [0.25-1.44],0.250937506565203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD302,CD302 antigen,Inverse variance weighted,9,0.9 [0.74-1.08],0.25164897492819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.65 [0.32-1.36],0.255476017144895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BCAN,Brevican core protein,Inverse variance weighted,3,0.84 [0.61-1.14],0.257817105254368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.15 [0.9-1.47],0.260064704441027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRH,Corticoliberin,Inverse variance weighted,11,0.92 [0.8-1.06],0.260914934219164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NCAN,Neurocan core protein,Inverse variance weighted,3,0.81 [0.56-1.17],0.261201825486549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.18 [0.88-1.59],0.262587076176136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL17C,Interleukin-17C,Inverse variance weighted,3,1.26 [0.84-1.89],0.26870916070718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BSG,Basigin,Wald ratio,1,0.8 [0.54-1.19],0.273652243756779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.11 [0.92-1.33],0.27391883864856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.13 [0.91-1.41],0.275814178548246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGB2,Integrin beta-2,Inverse variance weighted,4,0.84 [0.62-1.15],0.277149608771903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.93 [0.82-1.06],0.28023621098077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CPVL,Probable serine carboxypeptidase CPVL,Inverse variance weighted,28,0.95 [0.87-1.04],0.282002634592925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.46 [0.73-2.9],0.282913656549726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MB,Myoglobin,Wald ratio,1,2.24 [0.51-9.79],0.283230043120005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.07 [0.95-1.2],0.284554190112143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSE,Cathepsin E,Inverse variance weighted,14,1.07 [0.95-1.2],0.284858531905115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.29 [0.81-2.05],0.288929058075394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.09 [0.93-1.28],0.289211122754035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.05 [0.96-1.16],0.289341637408773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL15,Interleukin-15,Wald ratio,1,0.07 [0-9.39],0.289777512138315,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,1.23 [0.84-1.8],0.290476088838664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.95 [0.85-1.05],0.291261097854309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.1 [0.92-1.32],0.291631380971013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.12 [0.91-1.38],0.291699983815912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.95 [0.86-1.05],0.292214625716352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NRP1,Neuropilin-1,Inverse variance weighted,12,0.91 [0.75-1.09],0.292930760561837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD83,CD83 antigen,Inverse variance weighted,5,1.16 [0.88-1.54],0.294371410929678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.95 [0.85-1.05],0.29556078805025,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.53 [0.16-1.76],0.298633675269047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.15 [0.89-1.48],0.300972673979141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.69 [0.34-1.4],0.303304825000496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH6,Cadherin-6,Inverse variance weighted,29,0.95 [0.87-1.04],0.305738117875965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.78 [0.49-1.25],0.307065927489093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.93 [0.81-1.07],0.307399671727909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.05 [0.96-1.15],0.307452785744938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,4,0.81 [0.54-1.22],0.313931586597478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPOCK1,Testican-1,Inverse variance weighted,6,0.85 [0.63-1.16],0.315268919676104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.93 [0.81-1.07],0.317605113172354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.74 [0.41-1.33],0.31807625661969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.78 [0.47-1.28],0.318104505005665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL19,Interleukin-19,Inverse variance weighted,11,0.92 [0.77-1.09],0.319482258092854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.82 [0.56-1.21],0.321013837897663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.96 [0.88-1.04],0.321708668054342,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.78 [0.47-1.28],0.321889751137021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.1 [0.9-1.35],0.331907604915718,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,9,1.07 [0.94-1.21],0.338367218314275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LEPR,Leptin receptor,Inverse variance weighted,8,1.11 [0.9-1.38],0.338449517688924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.07 [0.93-1.22],0.341557627530381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,2.16 [0.44-10.57],0.341796922418252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.89 [0.71-1.13],0.343424130993845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD164,Sialomucin core protein 24,Inverse variance weighted,3,1.17 [0.84-1.64],0.358544902150128,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,F3,Tissue factor,Inverse variance weighted,11,1.13 [0.87-1.46],0.362620433731312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.92 [0.77-1.1],0.363238657508075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.14 [0.86-1.51],0.364753606981164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.96 [0.88-1.05],0.364815518886902,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CNTN2,Contactin-2,Inverse variance weighted,29,1.03 [0.96-1.11],0.365449427076589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSS,Cathepsin S,Inverse variance weighted,23,0.95 [0.85-1.06],0.36833077803948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,21,0.95 [0.85-1.06],0.369369736616172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.96 [0.87-1.05],0.372081101729023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.23 [0.78-1.96],0.373143964689818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,1.26 [0.76-2.07],0.373143964689818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLIN3,Perilipin-3,Wald ratio,1,0.71 [0.33-1.52],0.374348630474922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.61 [0.21-1.8],0.374464857071171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.06 [0.93-1.21],0.376552018361713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.12 [0.87-1.45],0.37815313615768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,F2R,Proteinase-activated receptor 1,Inverse variance weighted,2,0.71 [0.34-1.52],0.381191210808868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,10,0.89 [0.69-1.15],0.381258640786474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,1.04 [0.95-1.14],0.382142473027671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.17 [0.82-1.66],0.384139863572603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,0.94 [0.81-1.08],0.385226666432156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OSM,Oncostatin-M,Wald ratio,1,1.43 [0.64-3.2],0.386194809428595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.16 [0.83-1.63],0.386783409682981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.67 [0.27-1.66],0.390253946466086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.77 [0.48-6.57],0.391581400050578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MME,Neprilysin,Inverse variance weighted,3,0.75 [0.38-1.46],0.392036174151923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.96 [0.87-1.06],0.393287684739046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PI3,Elafin,Inverse variance weighted,10,0.93 [0.79-1.1],0.394399528931117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.14 [0.85-1.53],0.395876302683317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,1.36 [0.67-2.75],0.399102951517015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,24,1.03 [0.96-1.11],0.399537014918868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,36,0.96 [0.87-1.06],0.400446088930123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLK8,Kallikrein-8,Inverse variance weighted,12,0.94 [0.8-1.09],0.40360961785896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPO,Erythropoietin,Inverse variance weighted,5,0.76 [0.4-1.45],0.40362062017491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,0.76 [0.39-1.46],0.404037964709627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RGMA,Repulsive guidance molecule A,Inverse variance weighted,12,1.06 [0.92-1.23],0.405607029042892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.19 [0.79-1.81],0.405704170539459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.76 [0.47-6.62],0.405787723720972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,4,0.89 [0.68-1.17],0.40627872999529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.07 [0.91-1.26],0.408335576169546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.05 [0.93-1.19],0.4086852876208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,6,1.11 [0.86-1.43],0.409557284079622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.78 [0.43-1.41],0.411860328797271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.92 [0.75-1.12],0.415688247232096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.08 [0.89-1.32],0.42705591321225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.86 [0.4-8.58],0.428434978699946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AGRP,Agouti-related protein,Inverse variance weighted,3,1.26 [0.71-2.21],0.42974232808411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.8 [0.46-1.4],0.431761609730453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,0.96 [0.85-1.07],0.436622762170481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,1.04 [0.94-1.16],0.43677154409781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.11 [0.85-1.45],0.436809689910921,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPON2,Spondin-2,Inverse variance weighted,4,1.16 [0.79-1.7],0.437194955050337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,0.92 [0.74-1.14],0.439233161100151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,19,1.03 [0.95-1.13],0.440984957549152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,8,0.78 [0.41-1.48],0.444997724329735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCN3,CCN family member 3,Inverse variance weighted,19,1.07 [0.9-1.26],0.445581465251395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ELN,Elastin,Inverse variance weighted,2,1.58 [0.49-5.11],0.446152282621144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TMPRSS15,Enteropeptidase,Inverse variance weighted,3,0.85 [0.56-1.29],0.446886872894318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,43,0.98 [0.92-1.04],0.448431263682354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MILR1,Allergin-1,Inverse variance weighted,33,0.98 [0.92-1.04],0.452030281768944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCG2,Secretogranin-2,Wald ratio,1,0.64 [0.2-2.07],0.455303819879708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.88 [0.63-1.23],0.456134863553663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DPT,Dermatopontin,Inverse variance weighted,21,1.08 [0.89-1.31],0.458032574882467,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,1.07 [0.89-1.29],0.458381681238921,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.82 [0.49-1.38],0.459276955982894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1.09 [0.87-1.36],0.463808141867435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.8 [0.44-1.46],0.469257676260769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.94 [0.81-1.1],0.471417497461167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRTG,Protogenin,Inverse variance weighted,19,1.04 [0.94-1.15],0.472795010073319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRTN3,Myeloblastin,Inverse variance weighted,21,1.04 [0.93-1.17],0.47389323773355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.96 [0.86-1.07],0.475253870580458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TEK,Angiopoietin-1 receptor,Inverse variance weighted,13,1.04 [0.93-1.16],0.486297858379792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,0.95 [0.81-1.11],0.491226179854506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,0.95 [0.82-1.1],0.492161348742455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.05 [0.91-1.22],0.492518652234881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.93 [0.77-1.14],0.495978471719089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,0.87 [0.59-1.29],0.496982680600089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,THBS4,Thrombospondin-4,Inverse variance weighted,9,1.07 [0.88-1.29],0.497298003932821,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.12 [0.81-1.53],0.497391870359053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PGF,Placenta growth factor,Inverse variance weighted,2,0.61 [0.15-2.53],0.497696182989968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,0.94 [0.78-1.13],0.497742035795397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.93 [0.76-1.15],0.504846440014662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.05 [0.92-1.2],0.505980578408787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.89 [0.62-1.26],0.511809794822884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.17 [0.73-1.87],0.513177601301116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NECTIN4,Nectin-4,Inverse variance weighted,7,1.06 [0.9-1.25],0.516211517078506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AFP,Alpha-fetoprotein,Inverse variance weighted,5,0.92 [0.72-1.18],0.517715630021462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.69 [0.23-2.1],0.517792880199081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.83 [0.46-1.48],0.519600254521793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD160,CD160 antigen,Inverse variance weighted,11,1.05 [0.91-1.2],0.52018914214638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.16 [0.73-1.85],0.520725212432005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSD,Cathepsin D,Inverse variance weighted,17,0.95 [0.81-1.11],0.520762231166582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,1.06 [0.88-1.28],0.521123347843321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.4 [0.5-3.92],0.521912257837094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,24,0.97 [0.89-1.06],0.522110417618129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL18,Interleukin-18,Inverse variance weighted,16,1.1 [0.82-1.47],0.525910514402474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHGA,Chromogranin-A,Inverse variance weighted,3,1.09 [0.83-1.45],0.525911474373917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPC1,Glypican-1,Inverse variance weighted,17,1.05 [0.91-1.21],0.531708668741872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,0.98 [0.91-1.05],0.532481834630314,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.83 [0.45-1.5],0.533515993820154,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.97 [0.87-1.08],0.533989812832016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.12 [0.78-1.62],0.535291616484048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.64 [0.16-2.6],0.535555869056841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.42 [0.47-4.32],0.536895579761784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.96 [0.84-1.1],0.541224676579938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.21 [0.66-2.24],0.541751452147818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.96 [0.83-1.1],0.543461372348341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH3,Cadherin-3,Inverse variance weighted,2,1.22 [0.64-2.33],0.544507500775774,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.9 [0.64-1.27],0.546429864992179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.8 [0.39-1.64],0.547710206747623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.95 [0.78-1.14],0.551004432117637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,15,1.06 [0.88-1.28],0.556363756084252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS9,Galectin-9,Inverse variance weighted,26,1.04 [0.91-1.2],0.558439315870464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NPPC,C-type natriuretic peptide,Wald ratio,1,0.67 [0.18-2.55],0.560627464309026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.28 [0.55-2.99],0.563189201347213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RBP2,Retinol-binding protein 2,Wald ratio,1,0.77 [0.31-1.91],0.567117801526243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLK6,Kallikrein-6,Inverse variance weighted,4,1.08 [0.82-1.42],0.569472721660304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RSPO3,R-spondin-3,Inverse variance weighted,6,0.91 [0.64-1.28],0.57627024583031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPP1,Osteopontin,Inverse variance weighted,8,1.11 [0.76-1.62],0.579335605781637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.97 [0.89-1.07],0.58195226725754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.95 [0.8-1.13],0.583990964544106,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,1.03 [0.91-1.17],0.59097857917078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.2 [0.61-2.36],0.591864411250326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD46,Membrane cofactor protein,Wald ratio,1,1.19 [0.63-2.22],0.593074996069915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.98 [0.89-1.07],0.595269178139053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.93 [0.7-1.23],0.595654616055423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.02 [0.95-1.09],0.59779525804063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LCN15,Lipocalin-15,Inverse variance weighted,20,0.97 [0.88-1.07],0.598561800485223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH2,Cadherin-2,Inverse variance weighted,3,0.82 [0.4-1.7],0.599614277562385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,1.17 [0.65-2.12],0.600357293678303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.84 [0.44-1.6],0.601187738515598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1.03 [0.92-1.14],0.60218830350387,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CNTN4,Contactin-4,Inverse variance weighted,25,0.97 [0.86-1.09],0.603006646785977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VIT,Vitrin,Inverse variance weighted,25,1.02 [0.94-1.12],0.611524414708677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1.02 [0.94-1.11],0.613851873623673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD27,CD27 antigen,Inverse variance weighted,9,1.06 [0.85-1.31],0.61887508972606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.38 [0.39-4.94],0.619191592062033,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.1 [0.75-1.61],0.619412296244284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ALCAM,CD166 antigen,Inverse variance weighted,6,0.92 [0.65-1.3],0.619808622144706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP8,Neutrophil collagenase,Inverse variance weighted,17,0.97 [0.86-1.1],0.620043546133722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.02 [0.94-1.1],0.622801493671239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DSG3,Desmoglein-3,Inverse variance weighted,7,1.05 [0.86-1.29],0.623511739471348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,18,1.02 [0.93-1.12],0.623712476369903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.17 [0.63-2.16],0.62406097364474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.06 [0.83-1.37],0.624611903871526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,0.98 [0.9-1.06],0.625240174651157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.96 [0.83-1.12],0.627987135351044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.05 [0.85-1.31],0.62838133520022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.05 [0.87-1.27],0.628550354177115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LPO,Lactoperoxidase,Inverse variance weighted,4,1.04 [0.88-1.25],0.629575356870524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PALM,Paralemmin-1,Inverse variance weighted,6,0.91 [0.64-1.32],0.630286071438688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.03 [0.92-1.15],0.631312622062165,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SDC1,Syndecan-1,Inverse variance weighted,2,1.1 [0.74-1.64],0.632624460256443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.8 [0.32-1.99],0.633191607955978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.04 [0.88-1.23],0.633359285523494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.22 [0.53-2.78],0.636743464034264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.94 [0.73-1.22],0.636969870385037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.09 [0.75-1.59],0.637284207458146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.04 [0.88-1.24],0.637375011004421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.93 [0.67-1.27],0.638583704354049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.79 [0.29-2.16],0.639666251169897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1.04 [0.88-1.22],0.646147013510104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.92 [0.66-1.3],0.646778917174091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.88 [0.51-1.52],0.647627286880846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.04 [0.88-1.24],0.650905344677399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1.01 [0.95-1.08],0.651030938211537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.97 [0.84-1.12],0.651209541292201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,7,0.94 [0.73-1.22],0.657329486835268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.05 [0.84-1.32],0.658228456420305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.05 [0.84-1.31],0.659624068480391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRELP,Prolargin,Inverse variance weighted,9,0.96 [0.82-1.14],0.660444818146139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.03 [0.91-1.16],0.661739660439119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.06 [0.81-1.39],0.66238448691265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.02 [0.94-1.11],0.663939912249059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CST5,Cystatin-D,Inverse variance weighted,37,1.02 [0.94-1.1],0.667468106853994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,1.34 [0.35-5.21],0.670370281794578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.98 [0.91-1.06],0.672157799783749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1.06 [0.8-1.4],0.672994142728069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.93 [0.66-1.31],0.675224538719685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.96 [0.82-1.14],0.675483130712374,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.97 [0.86-1.1],0.675725717862963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.04 [0.87-1.23],0.67580490908804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.97 [0.84-1.12],0.676394341169126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.11 [0.69-1.79],0.677753151667617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.09 [0.73-1.6],0.680927089838851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PGA4,Pepsin A-4,Inverse variance weighted,2,1.17 [0.56-2.44],0.681088409165029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLK11,Kallikrein-11,Inverse variance weighted,6,1.02 [0.91-1.15],0.683727521572171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,1.13 [0.63-1.99],0.686067368998706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.02 [0.91-1.15],0.686991690935209,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.98 [0.91-1.07],0.689457380970583,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.81 [0.29-2.27],0.689801088037367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,0.98 [0.91-1.06],0.693958894200014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.93 [0.66-1.32],0.697862346871445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,0.84 [0.35-2.04],0.700152788751238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RETN,Resistin,Inverse variance weighted,9,0.98 [0.87-1.1],0.700764716759779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,0.92 [0.59-1.42],0.701680633777057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,10,1.03 [0.89-1.2],0.701819258882585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.12 [0.62-2.03],0.70317132287362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,1.11 [0.64-1.93],0.704917896142408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,0.98 [0.87-1.1],0.705566747985341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.05 [0.81-1.36],0.705916103280306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.03 [0.88-1.21],0.707682961420161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.98 [0.91-1.07],0.707702483168865,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.78 [0.21-2.92],0.708270057560145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.93 [0.65-1.34],0.708342574676766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.96 [0.79-1.17],0.708696620506764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.92 [0.59-1.43],0.710842647032533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.97 [0.8-1.16],0.713669006239435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.06 [0.79-1.42],0.715261269100517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.94 [0.69-1.29],0.719323793657753,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,0.93 [0.62-1.39],0.71990248717119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.98 [0.86-1.11],0.720805139483374,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.97 [0.81-1.15],0.722532516148967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.89 [0.46-1.72],0.724114533748743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.97 [0.8-1.16],0.725703220830514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.96 [0.77-1.2],0.726405496780461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.9 [0.48-1.68],0.730019616572593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,4,0.93 [0.62-1.39],0.732452984384764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.02 [0.92-1.12],0.73371694402663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.29 [0.29-5.75],0.735049882901254,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.02 [0.9-1.17],0.736803995111429,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,0.99 [0.91-1.07],0.736909986473838,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANPEP,Aminopeptidase N,Inverse variance weighted,23,0.98 [0.88-1.1],0.74198790623663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.03 [0.87-1.22],0.74280965790878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.93 [0.62-1.42],0.745473505695406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.98 [0.84-1.14],0.746122607706286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,S100P,Protein S100-P,Inverse variance weighted,2,0.88 [0.42-1.88],0.747862301195478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.81 [0.23-2.86],0.748403203940337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP10,Stromelysin-2,Inverse variance weighted,22,0.98 [0.86-1.12],0.75235257134049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.03 [0.84-1.28],0.759134116349417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.98 [0.86-1.12],0.759416595026761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.03 [0.84-1.27],0.759927353775151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.02 [0.89-1.17],0.762083358937229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DSC2,Desmocollin-2,Inverse variance weighted,9,0.97 [0.81-1.17],0.762883175273598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SELE,E-selectin,Inverse variance weighted,4,0.92 [0.55-1.55],0.76445228514445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.96 [0.74-1.24],0.764991243761504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.96 [0.75-1.23],0.767823516955986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.98 [0.86-1.12],0.767850799304698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VCAN,Versican core protein,Inverse variance weighted,31,0.99 [0.9-1.08],0.767984365284446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.91 [0.49-1.7],0.770726516756796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BOC,Brother of CDO,Inverse variance weighted,6,0.96 [0.73-1.27],0.776922024893752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP7,Matrilysin,Inverse variance weighted,13,1.03 [0.86-1.23],0.778079035674869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AREG,Amphiregulin,Inverse variance weighted,3,0.93 [0.56-1.54],0.778536679022502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.72 [0.07-7.43],0.779721597539913,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.03 [0.85-1.24],0.781026865406582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.98 [0.84-1.14],0.783947940566483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,0.99 [0.89-1.1],0.78641312940683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.98 [0.81-1.17],0.788722262096338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,0.89 [0.38-2.1],0.789122635165909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,0.97 [0.74-1.25],0.79091568745693,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,18,1.01 [0.92-1.12],0.79128489107103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.85 [0.26-2.81],0.791654784106103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.98 [0.81-1.17],0.792363054336943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.07 [0.64-1.78],0.794628573383633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.04 [0.79-1.36],0.796635442617059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RGMB,RGM domain family member B,Inverse variance weighted,9,0.96 [0.71-1.3],0.796865823161295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COLEC12,Collectin-12,Inverse variance weighted,11,0.97 [0.77-1.22],0.797082176028567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTRC,Chymotrypsin-C,Inverse variance weighted,16,1.02 [0.9-1.15],0.800511092433627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CALCA,Calcitonin,Inverse variance weighted,5,0.94 [0.58-1.53],0.800562007288686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.97 [0.8-1.19],0.80229001799785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1.06 [0.68-1.65],0.804241916531095,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CPA2,Carboxypeptidase A2,Inverse variance weighted,17,0.98 [0.86-1.13],0.80449419121102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CALB2,Calretinin,Wald ratio,1,1.12 [0.45-2.76],0.804652344573752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EDN1,Endothelin-1,Inverse variance weighted,3,0.97 [0.76-1.24],0.804736421150625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.06 [0.65-1.73],0.805230415217018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,THBD,Thrombomodulin,Inverse variance weighted,5,0.97 [0.74-1.27],0.805870306440558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CFD,Complement factor D,Inverse variance weighted,11,1.02 [0.86-1.22],0.805901772851087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.98 [0.87-1.12],0.807332854696471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.04 [0.77-1.39],0.808032231317553,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS4,Galectin-4,Inverse variance weighted,4,0.96 [0.68-1.35],0.810634998314494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.01 [0.92-1.11],0.814343433646814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPR15L,Protein GPR15L,Inverse variance weighted,9,0.98 [0.81-1.18],0.815433618409235,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,3,0.95 [0.63-1.44],0.816588855730061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.98 [0.8-1.19],0.819260997253166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.97 [0.75-1.26],0.824082060812119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.16 [0.31-4.28],0.824783305434404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.01 [0.92-1.11],0.827298924740522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.97 [0.75-1.26],0.834052118708462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANXA5,Annexin A5,Inverse variance weighted,2,1.06 [0.63-1.79],0.834483584532405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.98 [0.85-1.14],0.836805519413036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1.02 [0.85-1.22],0.838814837149057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,0.99 [0.86-1.13],0.839029045556379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.96 [0.61-1.49],0.84141846068631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.99 [0.88-1.11],0.8427875424291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.01 [0.88-1.18],0.845252090605084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,0.98 [0.75-1.26],0.848337686904645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,1.05 [0.64-1.72],0.84938883507994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LMNB2,Lamin-B2,Wald ratio,1,0.88 [0.22-3.44],0.849641943204233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.01 [0.9-1.14],0.849665334809153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,21,1.01 [0.87-1.18],0.851365650043864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.09 [0.45-2.6],0.852488694214606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.01 [0.91-1.13],0.852888729467837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGA5,Integrin alpha-5,Wald ratio,1,1.09 [0.43-2.79],0.854471104463036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.01 [0.89-1.16],0.856184501758593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.97 [0.68-1.37],0.856712377272482,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.03 [0.74-1.44],0.859699824699603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PCDH1,Protocadherin-1,Wald ratio,1,1.06 [0.54-2.1],0.860032529104998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.94 [0.5-1.8],0.862311981491684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.94 [0.48-1.85],0.863245826724712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.98 [0.77-1.25],0.863427002774778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.01 [0.91-1.12],0.864380731207472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HJV,Hemojuvelin,Wald ratio,1,1.03 [0.75-1.4],0.86929282291839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CSTB,Cystatin-B,Inverse variance weighted,28,1.01 [0.91-1.12],0.870934257311343,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CES2,Cocaine esterase,Wald ratio,1,1.08 [0.44-2.64],0.873687090269666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1 [0.94-1.05],0.873876660469217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.04 [0.64-1.7],0.874801223416827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,1.03 [0.68-1.56],0.875860044382036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL10,Interleukin-10,Wald ratio,1,0.96 [0.56-1.64],0.87668459278752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.01 [0.85-1.22],0.877208484906655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.03 [0.74-1.43],0.878475299343233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRSS27,Serine protease 27,Inverse variance weighted,5,0.98 [0.8-1.21],0.880304679529242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,22,1.01 [0.91-1.11],0.880318868087476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MSLN,Mesothelin,Inverse variance weighted,25,0.99 [0.91-1.08],0.887561548527306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.99 [0.8-1.21],0.887636176960632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.97 [0.62-1.52],0.888523944658768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHGB,Secretogranin-1,Inverse variance weighted,27,1.01 [0.9-1.13],0.889625568003542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.96 [0.52-1.77],0.891059014408561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.02 [0.76-1.38],0.892480536447958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGB6,Integrin beta-6,Inverse variance weighted,11,1.01 [0.83-1.24],0.893298125053561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.96 [0.55-1.7],0.89514494858184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CR2,Complement receptor type 2,Inverse variance weighted,6,1.02 [0.79-1.31],0.897242451760103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,10,1.02 [0.8-1.28],0.897281496901283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CST3,Cystatin-C,Inverse variance weighted,10,1.01 [0.85-1.2],0.897828190540944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.99 [0.91-1.09],0.898943008145281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.03 [0.63-1.69],0.901208411500188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.02 [0.74-1.42],0.901889031824804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1.02 [0.71-1.46],0.903681373381796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.97 [0.58-1.62],0.903974677655394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LYPD3,Ly6/PLAUR domain-containing protein 3,Inverse variance weighted,11,0.99 [0.86-1.15],0.906594296125974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.01 [0.85-1.2],0.909316988359204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,1.04 [0.56-1.94],0.909574885271908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.98 [0.64-1.49],0.911760292491699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OCLN,Occludin,Inverse variance weighted,2,0.98 [0.64-1.5],0.913381206916923,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.94 [0.28-3.12],0.914208248597313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.98 [0.72-1.34],0.915220590642015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.99 [0.75-1.29],0.921122654457495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.99 [0.79-1.24],0.922517040628005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.05 [0.41-2.68],0.926796719059885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AMBP,Protein AMBP,Inverse variance weighted,3,1.02 [0.7-1.48],0.92747885027823,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PALM2,Paralemmin-2,Inverse variance weighted,8,0.99 [0.79-1.24],0.927500829436144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,0.98 [0.56-1.69],0.928421488461952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.99 [0.84-1.17],0.932436803530655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DSCAM,Down syndrome cell adhesion molecule,Inverse variance weighted,11,1 [0.9-1.1],0.933456439136345,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1.01 [0.88-1.15],0.937015108985268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD109,CD109 antigen,Inverse variance weighted,45,1 [0.93-1.08],0.937051777068128,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,1 [0.9-1.11],0.938549094700661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.99 [0.8-1.23],0.938672033591656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGB7,Integrin beta-7,Inverse variance weighted,3,1.01 [0.69-1.48],0.939905300888558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1 [0.88-1.14],0.942509558871605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.03 [0.43-2.5],0.942782625921335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.99 [0.82-1.2],0.946329473865744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,1 [0.92-1.1],0.946921417798788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1 [0.89-1.13],0.947550609003704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1 [0.91-1.09],0.955110715220754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1 [0.88-1.15],0.955696738718319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1 [0.86-1.17],0.959269881099594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.99 [0.56-1.73],0.959906369832603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRSS8,Prostasin,Inverse variance weighted,5,1.01 [0.65-1.57],0.960609326802896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.99 [0.78-1.26],0.961661014741527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.99 [0.78-1.27],0.96393725708527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MSMB,Beta-microseminoprotein,Inverse variance weighted,64,1 [0.91-1.1],0.964573456494974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.01 [0.72-1.41],0.965045472958178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.93-1.08],0.969596746365306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.01 [0.77-1.32],0.971087521853058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1 [0.87-1.15],0.974217450877766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PENK,Proenkephalin-A,Inverse variance weighted,19,1 [0.82-1.21],0.975947995179408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1 [0.71-1.4],0.977780659554122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1 [0.78-1.28],0.979440615567068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1 [0.88-1.13],0.979697986617268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCN4,CCN family member 4,Inverse variance weighted,27,1 [0.89-1.12],0.985155715932332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RTBDN,Retbindin,Inverse variance weighted,3,1 [0.73-1.36],0.986807708655319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1 [0.69-1.45],0.991537363734464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1 [0.4-2.49],0.992941906502233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1 [0.92-1.09],0.993523800106034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,1 [0.65-1.54],0.994157237851668,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,11,1 [0.75-1.34],0.995009223413216,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1 [0.51-1.98],0.995251897773292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VASN,Vasorin,Inverse variance weighted,14,1 [0.9-1.11],0.99539967165262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1 [0.78-1.27],0.996316712309243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1 [0.8-1.25],0.999582908881716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.41 [0.24-0.71],0.00158209057336422,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.16 [0.05-0.5],0.0016357686054875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.85 [1.24-2.75],0.0024341476485413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,2.01 [1.28-3.15],0.00253169256201623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.39 [0.2-0.74],0.0045546382451259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MB,Myoglobin,Inverse variance weighted,9,0.59 [0.4-0.86],0.00571691887876962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,3.26 [1.41-7.56],0.00580831184536866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSO,Cathepsin O,Inverse variance weighted,19,1.24 [1.06-1.46],0.00619939650167336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.35 [1.08-1.68],0.00737867704054494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.81 [0.69-0.95],0.0103043252912813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.09 [1.02-1.16],0.0114560946971548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,3.91 [1.34-11.46],0.0127861386186214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.34 [0.15-0.8],0.0128311962891196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.59 [0.39-0.9],0.014488515599725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.55 [0.34-0.89],0.0155943376237724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.77 [0.62-0.95],0.0172005554986411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.13 [1.02-1.26],0.0196913373364085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.6 [1.08-2.39],0.0202922191003268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,3.36 [1.19-9.48],0.0217826761523632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.42 [0.2-0.88],0.0220571500872459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PVR,Poliovirus receptor,Inverse variance weighted,3,0.41 [0.19-0.88],0.0228287095877387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.55 [0.32-0.92],0.0230351917667886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.5 [0.27-0.91],0.0239598781682185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,0.47 [0.24-0.92],0.0270114695481209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.88 [1.07-3.3],0.0274745882737841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.32 [0.12-0.89],0.0282627131649887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.62 [1.03-2.55],0.0355036521498764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.7 [0.51-0.98],0.0364021525318752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD27,CD27 antigen,Inverse variance weighted,9,0.59 [0.36-0.97],0.037490981053577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CFC1,Cryptic protein,Inverse variance weighted,11,0.69 [0.48-0.99],0.042738487733773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.32 [1.01-1.74],0.0449377098294713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GRN,Progranulin,Inverse variance weighted,46,1.11 [1-1.22],0.0450307969943096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,1.09 [1-1.18],0.0482894839738601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OGN,Mimecan,Inverse variance weighted,37,1.12 [1-1.25],0.0488074888065901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGB6,Integrin beta-6,Inverse variance weighted,16,0.79 [0.63-1],0.0511844282496213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.17 [1-1.38],0.0538059524603891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.76 [0.58-1.01],0.0543275330214768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.34 [0.99-1.82],0.0560560206953806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.35 [0.99-1.85],0.0569491285400814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,17,1.2 [0.99-1.46],0.0575449072483244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANPEP,Aminopeptidase N,Inverse variance weighted,2,2.32 [0.96-5.6],0.0611695240613208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NRP1,Neuropilin-1,Inverse variance weighted,14,0.72 [0.51-1.02],0.0617433764004919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,2.07 [0.96-4.46],0.0630292510786262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.69 [0.46-1.02],0.0637693330157577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,0.82 [0.66-1.01],0.0656041028206049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1.61 [0.97-2.67],0.068313680739585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHAD,Chondroadherin,Inverse variance weighted,15,1.14 [0.99-1.31],0.0689822290203931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SERPINB8,Serpin B8,Inverse variance weighted,29,0.94 [0.87-1.01],0.0696033514760818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,1.1 [0.99-1.22],0.07668862574687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.45 [0.96-2.19],0.0770148122280124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.64 [0.38-1.05],0.078779378482158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.52 [0.95-2.44],0.0796037445982109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IDI2,Isopentenyl-diphosphate delta-isomerase 2,Inverse variance weighted,3,0.38 [0.13-1.13],0.0817592555430825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.14 [0.98-1.32],0.0859106462202547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,3.28 [0.84-12.79],0.0871216682890799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.25 [0.97-1.62],0.0889868965688033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1.19 [0.97-1.45],0.0906430703336842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MSLN,Mesothelin,Inverse variance weighted,11,1.31 [0.96-1.79],0.0927648794090911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.64 [0.38-1.09],0.0994120004350542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MME,Neprilysin,Inverse variance weighted,46,1.1 [0.98-1.23],0.0998545085523428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,2.95 [0.81-10.7],0.100183457655225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.86 [0.72-1.03],0.100592657755749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.24 [0.96-1.6],0.100886570049574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.47 [0.19-1.17],0.105666266581726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS4,Galectin-4,Inverse variance weighted,15,0.88 [0.76-1.03],0.109929122027545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,12,1.31 [0.94-1.84],0.110825766722379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD109,CD109 antigen,Inverse variance weighted,36,1.09 [0.98-1.22],0.112000578022976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,0.83 [0.67-1.04],0.11418949510969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.85 [0.7-1.04],0.115247009593991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RETN,Resistin,Inverse variance weighted,19,0.83 [0.66-1.05],0.11534553169257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.87 [0.72-1.04],0.121248013625952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CFD,Complement factor D,Wald ratio,1,2.51 [0.78-8.08],0.122234321716307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,1.15 [0.96-1.37],0.125216070351206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,1.56 [0.88-2.76],0.127625607673418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRSS27,Serine protease 27,Inverse variance weighted,47,1.08 [0.98-1.2],0.128032146948239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.94 [0.86-1.02],0.13053140027905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.37 [0.91-2.06],0.131964232072864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD160,CD160 antigen,Inverse variance weighted,24,1.17 [0.95-1.44],0.138139382282299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PCDH17,Protocadherin-17,Inverse variance weighted,44,1.07 [0.98-1.17],0.138274764942314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.59 [0.29-1.19],0.138507539784557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.65 [0.37-1.15],0.139141634355198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.91 [0.8-1.03],0.140138928342435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,UMOD,Uromodulin,Inverse variance weighted,34,0.85 [0.69-1.05],0.141237898529246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.71 [0.46-1.12],0.141976585336094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.81 [0.6-1.08],0.144171932874138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.62 [0.32-1.18],0.146496832806251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSL,Cathepsin L1,Inverse variance weighted,29,1.14 [0.95-1.37],0.149848803564668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CNTN4,Contactin-4,Inverse variance weighted,12,0.78 [0.56-1.09],0.150166608519739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPON2,Spondin-2,Inverse variance weighted,3,0.47 [0.17-1.32],0.151823436363957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.07 [0.98-1.16],0.152154793299691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.14 [0.95-1.35],0.152621238590359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,0.63 [0.33-1.21],0.164470572924605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.68 [0.4-1.17],0.165698051648675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,30,1.15 [0.94-1.41],0.167564678980808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.65 [0.35-1.2],0.169664578434161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.87 [0.71-1.06],0.170041409074166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,38,0.91 [0.79-1.04],0.170558891496445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.87 [0.72-1.06],0.173591695655571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,0.7 [0.42-1.17],0.173976834313009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPON1,Spondin-1,Inverse variance weighted,4,1.48 [0.84-2.62],0.174511161948379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OLFM4,Olfactomedin-4,Inverse variance weighted,29,1.17 [0.93-1.46],0.178552232554533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,13,1.25 [0.9-1.73],0.181359077722503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.79 [0.55-1.12],0.182020116054451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,0.73 [0.46-1.16],0.182531963270869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,1.18 [0.93-1.49],0.183107248083978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.2 [0.92-1.56],0.183177529975733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,0.71 [0.42-1.19],0.191509180665549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GCG,Pro-glucagon,Inverse variance weighted,2,0.57 [0.24-1.33],0.192516410546295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.78 [0.74-4.25],0.195384854144698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.61 [0.29-1.29],0.196099833333043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.65 [0.34-1.25],0.196644057589754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AGRN,Agrin,Inverse variance weighted,14,0.8 [0.57-1.12],0.198371520705772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.2 [0.91-1.57],0.199426518754434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.45 [0.13-1.53],0.200713649636315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.54 [0.21-1.41],0.207228283192169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CPA2,Carboxypeptidase A2,Inverse variance weighted,10,0.75 [0.49-1.17],0.208047872728352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.87 [0.71-1.08],0.210223218576114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.31 [0.86-2.01],0.210486465341902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,0.8 [0.57-1.14],0.216161010802792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH1,Cadherin-1,Inverse variance weighted,16,0.86 [0.69-1.09],0.217051485827249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.44 [0.8-2.58],0.218982137691698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.47 [0.14-1.57],0.220643975724408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MSMB,Beta-microseminoprotein,Inverse variance weighted,52,1.05 [0.97-1.13],0.221831492691549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,1.21 [0.89-1.66],0.225177825600436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.87 [0.7-1.09],0.227942209092473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VASN,Vasorin,Inverse variance weighted,5,1.49 [0.78-2.87],0.228377503113121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.53 [0.19-1.49],0.230384939550649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.25 [0.87-1.82],0.230448636104422,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.26 [0.86-1.85],0.23451532926412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH15,Cadherin-15,Inverse variance weighted,4,0.66 [0.33-1.31],0.236648579339903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.9 [0.76-1.07],0.237600585945053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.85 [0.64-1.12],0.245062108438029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,22,0.87 [0.69-1.1],0.245142873846874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.13 [0.92-1.38],0.247458233890746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,0.44 [0.11-1.77],0.247977829275395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.31 [0.83-2.08],0.249476669618445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.33 [0.82-2.14],0.24995805141766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.71 [0.4-1.27],0.2531559972215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,2.2 [0.57-8.47],0.253361914521685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.16 [0.9-1.51],0.253522302465124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.67 [0.33-1.34],0.255801758734955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COLEC12,Collectin-12,Inverse variance weighted,3,1.91 [0.62-5.89],0.25797974086202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD48,CD48 antigen,Inverse variance weighted,14,1.2 [0.88-1.64],0.258017708582929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DCN,Decorin,Inverse variance weighted,2,0.57 [0.22-1.51],0.258111849579646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.59 [0.71-3.56],0.261129581792405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL6,Interleukin-6,Inverse variance weighted,6,0.81 [0.55-1.17],0.262336827476617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.16 [0.89-1.51],0.264343740619535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.86 [0.65-1.13],0.264804561537901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.89 [0.73-1.09],0.265509884358438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRH,Corticoliberin,Inverse variance weighted,55,1.07 [0.95-1.19],0.267070783226153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CES2,Cocaine esterase,Inverse variance weighted,4,1.65 [0.68-4.01],0.26965591404834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PCDH1,Protocadherin-1,Inverse variance weighted,4,0.8 [0.53-1.19],0.272279884670167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.16 [0.89-1.51],0.275487048813934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,0.44 [0.1-1.95],0.279263551851209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.35 [0.78-2.31],0.281302316920287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.95 [0.58-6.59],0.28245996876963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.21 [0.86-1.71],0.283894467697929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSD,Cathepsin D,Inverse variance weighted,7,1.27 [0.82-1.96],0.285083509696704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,2.03 [0.55-7.51],0.286394324122862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.8 [0.53-1.21],0.288080632777845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PSAP,Prosaposin,Inverse variance weighted,13,0.89 [0.73-1.1],0.291223682410691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.27 [0.82-1.97],0.291347497797762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.77 [0.47-1.26],0.29258854255741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.15 [0.89-1.48],0.296441280228423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.81 [0.54-1.21],0.299464632467437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1.17 [0.87-1.56],0.299970814046678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.65 [0.28-1.48],0.299978005434093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPO,Erythropoietin,Inverse variance weighted,11,0.89 [0.71-1.11],0.301453565549483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,1.13 [0.9-1.42],0.302081837442002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.2 [0.85-1.7],0.303096413411292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXCL8,Interleukin-8,Inverse variance weighted,8,1.19 [0.85-1.65],0.30472585343206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.36 [0.75-2.45],0.306595648680562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.25 [0.81-1.93],0.309608837132595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,1.15 [0.88-1.49],0.311748768180234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.68 [0.33-1.43],0.313788355100748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCN4,CCN family member 4,Inverse variance weighted,29,0.93 [0.81-1.07],0.314008914203021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.07 [0.94-1.21],0.314531332763576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP7,Matrilysin,Wald ratio,1,1.3 [0.78-2.15],0.31846970095108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.14 [0.88-1.46],0.31907885448845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,0.9 [0.72-1.11],0.324141431626745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,F2R,Proteinase-activated receptor 1,Inverse variance weighted,6,1.23 [0.81-1.86],0.324446344212113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.76 [0.44-1.31],0.324863689346213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRELP,Prolargin,Inverse variance weighted,5,0.7 [0.34-1.43],0.325486185562503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.83 [0.57-1.2],0.32629106140667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.85 [0.62-1.18],0.326503257819289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.95 [0.85-1.06],0.327170828226799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,0.93 [0.82-1.07],0.328166845845655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRTG,Protogenin,Inverse variance weighted,8,1.27 [0.78-2.05],0.332362741334962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SEPTIN8,Septin-8,Inverse variance weighted,4,1.28 [0.77-2.13],0.333880904642012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AREG,Amphiregulin,Inverse variance weighted,5,0.76 [0.44-1.32],0.33503456994054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,1.15 [0.86-1.54],0.335919642317236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.39 [0.71-2.74],0.336340987987406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MILR1,Allergin-1,Inverse variance weighted,43,0.97 [0.91-1.03],0.336767111370532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ELN,Elastin,Inverse variance weighted,10,0.8 [0.52-1.25],0.3371571476383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.11 [0.9-1.38],0.338365519944184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,10,0.83 [0.56-1.22],0.33920498784862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.17 [0.85-1.63],0.340517939808518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGB7,Integrin beta-7,Inverse variance weighted,42,1.07 [0.93-1.22],0.34352794489506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,1.19 [0.82-1.72],0.352111346821607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.12 [0.88-1.41],0.352401188730123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BOC,Brother of CDO,Inverse variance weighted,8,1.19 [0.82-1.72],0.355121902813119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.14 [0.86-1.53],0.356837359016005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SDC1,Syndecan-1,Inverse variance weighted,12,0.88 [0.66-1.16],0.358098035974335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSS,Cathepsin S,Inverse variance weighted,7,1.21 [0.81-1.81],0.36000659102896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.84 [0.57-1.23],0.362132758136561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.05 [0.95-1.16],0.36225897289574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.87 [0.65-1.17],0.362283858203173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD164,Sialomucin core protein 24,Inverse variance weighted,8,1.16 [0.84-1.59],0.364453967402839,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.74 [0.39-1.42],0.369765650035659,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CST3,Cystatin-C,Inverse variance weighted,3,1.41 [0.66-2.98],0.370945851556171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLK8,Kallikrein-8,Inverse variance weighted,5,0.77 [0.43-1.37],0.371381073012986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.61 [0.21-1.8],0.374464857071171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,WNT9A,Protein Wnt-9a,Wald ratio,1,2.01 [0.43-9.52],0.377904943307362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.09 [0.9-1.32],0.379954426075597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.65 [0.25-1.69],0.380444535384374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.92 [0.44-8.31],0.385640884296956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.81 [0.5-1.31],0.386814218833328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.04 [0.95-1.13],0.389983180359883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.83 [0.53-1.28],0.390544475139698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,0.88 [0.66-1.18],0.392804441376817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD46,Membrane cofactor protein,Inverse variance weighted,2,1.67 [0.51-5.5],0.397169123241954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.69 [0.5-5.7],0.399602974205536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.17 [0.8-1.71],0.404553323334382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ALCAM,CD166 antigen,Inverse variance weighted,4,0.82 [0.51-1.32],0.40755160488189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.91 [0.72-1.15],0.409787467874747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.18 [0.8-1.73],0.411268903929074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.14 [0.83-1.56],0.411371676219447,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.25 [0.73-2.13],0.411730175895492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGB2,Integrin beta-2,Inverse variance weighted,20,0.92 [0.76-1.12],0.417053259151964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.75 [0.37-1.52],0.426889025331846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,7,1.2 [0.76-1.89],0.42787567145665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.9 [0.68-1.18],0.428821446305565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.96 [0.87-1.06],0.429513417788864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,0.92 [0.74-1.13],0.429828446582318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.05 [0.93-1.2],0.430588318290378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.18 [0.78-1.81],0.431845893148825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD70,CD70 antigen,Inverse variance weighted,11,1.09 [0.88-1.35],0.432568020166126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,1.23 [0.73-2.09],0.434675453939001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCN3,CCN family member 3,Inverse variance weighted,17,1.07 [0.91-1.26],0.436054698596269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,0.7 [0.28-1.75],0.440879862029133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.16 [0.8-1.69],0.441166493939017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.16 [0.79-1.71],0.443461818681186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.15 [0.8-1.65],0.445363150823609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.94 [0.8-1.1],0.445490973432247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.05 [0.93-1.18],0.450260312454333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.84 [0.54-1.32],0.451453623481343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DSG2,Desmoglein-2,Inverse variance weighted,22,1.07 [0.9-1.26],0.451547988111727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HEPH,Hephaestin,Inverse variance weighted,6,0.91 [0.71-1.16],0.452729355197323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.69 [0.27-1.81],0.453119871624248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.08 [0.89-1.3],0.454078696231126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,19,0.91 [0.72-1.16],0.454967092423336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.36 [0.6-3.07],0.455274636358527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.16 [0.79-1.71],0.455445486531929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPP1,Osteopontin,Inverse variance weighted,13,1.14 [0.81-1.59],0.458128931220503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,POF1B,Protein POF1B,Inverse variance weighted,4,1.2 [0.74-1.96],0.461664820799406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH2,Cadherin-2,Inverse variance weighted,21,0.92 [0.74-1.15],0.46186199459736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.4 [0.57-3.47],0.464052579567254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.05 [0.92-1.21],0.464664017000288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.21 [0.72-2.06],0.471681958055496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,6,1.35 [0.6-3.06],0.47289836099565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.14 [0.79-1.65],0.473442091524828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,17,1.1 [0.85-1.43],0.480425280961843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.88 [0.62-1.26],0.482547113527831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.14 [0.79-1.63],0.483554967034812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.82 [0.46-1.44],0.483768591941408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.91 [0.69-1.2],0.486465522547254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD83,CD83 antigen,Inverse variance weighted,14,1.11 [0.83-1.48],0.487860062714971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.1 [0.83-1.46],0.488418427674194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.23 [0.68-2.24],0.49044556916748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.14 [0.78-1.66],0.492086253003261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.92 [0.72-1.17],0.50153645560142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.06 [0.89-1.27],0.501796866210538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.75 [0.33-1.73],0.502834845263688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.25 [0.65-2.42],0.503280702940802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.95 [0.82-1.1],0.503343200388723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.04 [0.92-1.17],0.508847460501692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.27 [0.62-2.62],0.509699588860787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.93 [0.74-1.16],0.512009603837184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VIT,Vitrin,Inverse variance weighted,10,1.11 [0.82-1.5],0.512299552290773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.13 [0.78-1.66],0.513603810639392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,8,1.13 [0.78-1.63],0.513841633448596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.39 [0.51-3.78],0.514459021793153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLK6,Kallikrein-6,Inverse variance weighted,2,0.52 [0.07-3.78],0.514922864940243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPR15L,Protein GPR15L,Inverse variance weighted,13,0.94 [0.78-1.13],0.518330592985975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.74 [0.3-1.83],0.520300827501281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,19,0.93 [0.76-1.15],0.521164133786002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OSM,Oncostatin-M,Inverse variance weighted,6,1.12 [0.79-1.6],0.522890142577982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.34 [0.54-3.33],0.524840680862212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.91 [0.68-1.22],0.525719707651007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.23 [0.64-2.37],0.526356834625461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.94 [0.76-1.15],0.527042603156275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,1.2 [0.68-2.14],0.529773432848166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.21 [0.67-2.2],0.531121958030648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.1 [0.81-1.5],0.531244886156113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.88 [0.59-1.32],0.531933186106139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP3,Stromelysin-1,Inverse variance weighted,4,0.77 [0.34-1.75],0.532757023580059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,15,0.88 [0.6-1.3],0.532843919596903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.1 [0.81-1.49],0.532855583132984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.1 [0.81-1.49],0.532968360131898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCG2,Secretogranin-2,Inverse variance weighted,2,0.75 [0.31-1.83],0.533541536358497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.93 [0.73-1.18],0.535241889691162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PKD1,Polycystin-1,Inverse variance weighted,12,1.12 [0.79-1.58],0.535411145865286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,1.28 [0.59-2.79],0.53812546675296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.95 [0.81-1.12],0.544646533449462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,1.13 [0.76-1.68],0.545129820257165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,0.91 [0.68-1.23],0.54513732887901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.09 [0.83-1.44],0.547970831921075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.3 [0.54-3.13],0.551754766725011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,0.88 [0.57-1.35],0.55345947151092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ACRV1,Acrosomal protein SP-10,Wald ratio,1,0.57 [0.09-3.68],0.553863511882047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RSPO3,R-spondin-3,Inverse variance weighted,5,0.84 [0.47-1.51],0.554424403371358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.85 [0.5-1.46],0.555837240461807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.31 [0.53-3.26],0.557620458719828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.84 [0.48-1.49],0.558205215974347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.06 [0.86-1.32],0.564591532631269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.87 [0.54-1.4],0.564630343604222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.1 [0.79-1.53],0.566679321127108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.06 [0.87-1.28],0.569145777643046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTSE,Cathepsin E,Inverse variance weighted,8,0.88 [0.56-1.37],0.570263948685126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.89 [0.59-1.33],0.570455500686598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.09 [0.81-1.45],0.571810236037176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VCAN,Versican core protein,Inverse variance weighted,30,0.94 [0.78-1.15],0.571930029527927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DPT,Dermatopontin,Inverse variance weighted,4,0.78 [0.33-1.85],0.57399147974913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.07 [0.84-1.37],0.578098036906022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,S100P,Protein S100-P,Inverse variance weighted,4,0.88 [0.58-1.36],0.578230582777832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,16,0.96 [0.85-1.09],0.578315531156537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.12 [0.74-1.71],0.581934041975344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.74 [0.25-2.18],0.582064847350512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.18 [0.65-2.13],0.582689702035757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.11 [0.75-1.64],0.586183133728348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,0.81 [0.38-1.74],0.587434453607651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,0.69 [0.17-2.69],0.588678718862649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CALCA,Calcitonin,Inverse variance weighted,13,0.91 [0.65-1.28],0.58931561645608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.9 [0.61-1.33],0.592650380284227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.94 [0.73-1.19],0.592910782303049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL18,Interleukin-18,Inverse variance weighted,26,1.04 [0.9-1.2],0.593570957526017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OCLN,Occludin,Inverse variance weighted,2,0.81 [0.37-1.77],0.594052554597413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.91 [0.63-1.3],0.594063011669441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.08 [0.82-1.41],0.594640691780378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.06 [0.85-1.34],0.597597243509462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CPVL,Probable serine carboxypeptidase CPVL,Inverse variance weighted,19,1.08 [0.81-1.43],0.599002615956377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.28 [0.51-3.21],0.599311729429092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,0.93 [0.71-1.21],0.599509494846482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.64 [0.12-3.4],0.601140455866454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL15,Interleukin-15,Inverse variance weighted,35,0.94 [0.74-1.19],0.60236274416714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PALM,Paralemmin-1,Inverse variance weighted,4,1.2 [0.6-2.42],0.602617911292512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.94 [0.76-1.17],0.602995432190302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.94 [0.75-1.18],0.605162784681046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.16 [0.66-2.05],0.608203338593409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.07 [0.82-1.4],0.613467411352934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,0.95 [0.77-1.17],0.613897345556291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.87 [0.51-1.5],0.6151982667441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.87 [0.51-1.5],0.619046867259699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.92 [0.65-1.29],0.621716156859057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.07 [0.82-1.4],0.625548012526308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.81 [0.35-1.88],0.625757335033071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.06 [0.83-1.37],0.62721270951516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.9 [0.6-1.36],0.627963906950271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.97 [0.87-1.09],0.628197099422052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,1.06 [0.84-1.34],0.632075095387948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.84 [0.41-1.71],0.632498258844512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.93 [0.69-1.26],0.636403553992298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TMPRSS11D,Transmembrane protease serine 11D,Wald ratio,1,0.74 [0.22-2.54],0.636906323055193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MDK,Midkine,Inverse variance weighted,14,1.08 [0.79-1.48],0.637368120022308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.16 [0.62-2.16],0.640948279407107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.92 [0.64-1.32],0.642439192361044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LCN15,Lipocalin-15,Inverse variance weighted,22,0.97 [0.87-1.09],0.64461965028222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.04 [0.87-1.26],0.647219688018549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,59,1.02 [0.93-1.12],0.650178365699121,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,1.1 [0.73-1.64],0.650841872061421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,F3,Tissue factor,Inverse variance weighted,13,1.08 [0.77-1.51],0.654973354031177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.07 [0.79-1.46],0.658570166474918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NECTIN2,Nectin-2,Inverse variance weighted,3,1.22 [0.5-3.01],0.658895631597223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.86 [0.43-1.7],0.660459883082895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.13 [0.66-1.93],0.661139366071908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CNTN2,Contactin-2,Inverse variance weighted,11,0.9 [0.56-1.44],0.662180914796462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.97 [0.87-1.09],0.663689293443636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.97 [0.84-1.12],0.665098527217645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SELE,E-selectin,Inverse variance weighted,20,0.97 [0.86-1.1],0.667740459245941,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.02 [0.92-1.15],0.668728185990385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.93 [0.66-1.3],0.675139825065944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.93 [0.66-1.31],0.675224538719685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CST5,Cystatin-D,Inverse variance weighted,29,0.95 [0.75-1.2],0.675357406864351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.85 [0.39-1.85],0.678148196733501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH6,Cadherin-6,Inverse variance weighted,5,1.12 [0.65-1.95],0.678799939237854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CX3CL1,Fractalkine,Inverse variance weighted,12,1.11 [0.68-1.81],0.6788860482807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.91 [0.57-1.45],0.679690155890431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.88 [0.49-1.6],0.680125053414638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,15,0.93 [0.65-1.32],0.680660265529141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.06 [0.8-1.4],0.680826039759444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.02 [0.94-1.1],0.682271039109825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.75 [0.19-3.02],0.684452622822634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHGA,Chromogranin-A,Inverse variance weighted,5,0.9 [0.53-1.52],0.685273068486538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LYPD3,Ly6/PLAUR domain-containing protein 3,Inverse variance weighted,21,0.96 [0.8-1.16],0.687471129999252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANG,Angiogenin,Inverse variance weighted,8,0.9 [0.53-1.51],0.687826213792414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.09 [0.71-1.68],0.689064498525025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.78 [0.22-2.7],0.691036898693769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,0.89 [0.5-1.58],0.694910672681258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCN5,CCN family member 5,Inverse variance weighted,12,0.96 [0.8-1.16],0.695375783368789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,16,0.95 [0.75-1.21],0.696487970454815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DRAXIN,Draxin,Inverse variance weighted,25,1.05 [0.84-1.31],0.69652042117602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NCAN,Neurocan core protein,Inverse variance weighted,19,0.95 [0.75-1.21],0.697165077197705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.38 [0.27-7.06],0.699610883994861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REN,Renin,Inverse variance weighted,8,1.08 [0.73-1.61],0.700928613828268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.93 [0.64-1.35],0.703807197192986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,1.06 [0.8-1.4],0.705143292353102,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.03 [0.89-1.18],0.705713521591449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,0.97 [0.82-1.15],0.706317196779865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL22,Interleukin-22,Inverse variance weighted,4,0.85 [0.35-2.02],0.70634374684263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.06 [0.78-1.43],0.706681620530123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TEK,Angiopoietin-1 receptor,Inverse variance weighted,13,1.02 [0.92-1.14],0.708098642237437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.94 [0.68-1.3],0.710311120037936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MUC13,Mucin-13,Inverse variance weighted,3,1.15 [0.54-2.47],0.711184091033851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NECTIN4,Nectin-4,Inverse variance weighted,4,1.13 [0.6-2.12],0.71291671320007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.04 [0.85-1.26],0.714003033494275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL17C,Interleukin-17C,Inverse variance weighted,5,1.11 [0.64-1.91],0.715503595580236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PGF,Placenta growth factor,Inverse variance weighted,5,0.92 [0.59-1.44],0.716325409464497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.97 [0.82-1.15],0.720265494977765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LPO,Lactoperoxidase,Inverse variance weighted,29,1.02 [0.92-1.13],0.723056543818362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.08 [0.7-1.68],0.72487009138013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AGR3,Anterior gradient protein 3,Inverse variance weighted,5,1.11 [0.61-2.01],0.727606409501362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,13,1.06 [0.78-1.43],0.7288172238486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.94 [0.66-1.34],0.729343744933386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.06 [0.75-1.51],0.734342612020947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.06 [0.75-1.49],0.734501986544899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.08 [0.7-1.66],0.735269827513401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BSG,Basigin,Inverse variance weighted,6,0.91 [0.52-1.58],0.738085236657533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,0.96 [0.78-1.2],0.740752371697764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.98 [0.89-1.08],0.741632649254872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.1 [0.62-1.96],0.744495161134391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,0.94 [0.64-1.38],0.746124299714328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.03 [0.87-1.21],0.750693261600339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BCAN,Brevican core protein,Inverse variance weighted,12,0.93 [0.58-1.48],0.751408881646967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,C7,Complement component C7,Inverse variance weighted,26,1.02 [0.91-1.14],0.754437511123351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.02 [0.91-1.14],0.754779572672428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RTBDN,Retbindin,Inverse variance weighted,2,0.89 [0.43-1.86],0.755059251052007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,1.14 [0.49-2.69],0.757139679157304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RGMB,RGM domain family member B,Inverse variance weighted,5,0.86 [0.34-2.22],0.759787793643826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,9,0.95 [0.68-1.33],0.760207438026477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.96 [0.75-1.23],0.761022110277492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.95 [0.69-1.31],0.764490868379472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.08 [0.64-1.84],0.767757385809993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PYY,Peptide YY,Inverse variance weighted,16,1.03 [0.83-1.28],0.767905371911192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,0.99 [0.9-1.08],0.768772698685897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MMP10,Stromelysin-2,Wald ratio,1,1.23 [0.3-5.01],0.77247829658995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PENK,Proenkephalin-A,Inverse variance weighted,15,1.05 [0.76-1.43],0.77355844062547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.95 [0.69-1.31],0.77360266583431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DSCAM,Down syndrome cell adhesion molecule,Inverse variance weighted,24,0.99 [0.89-1.09],0.774280344911631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.05 [0.76-1.46],0.774490599931046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.94 [0.6-1.47],0.77626485463231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.94 [0.62-1.44],0.777810942260096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.03 [0.82-1.3],0.780285750987251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.94 [0.6-1.47],0.784648039926402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TMPRSS15,Enteropeptidase,Inverse variance weighted,11,0.97 [0.77-1.22],0.785141157932663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,0.96 [0.73-1.27],0.786375281403539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD276,CD276 antigen,Inverse variance weighted,24,0.97 [0.8-1.19],0.788812604350813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.94 [0.6-1.47],0.789931331850604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.98 [0.87-1.12],0.793728316770591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.3 [0.18-9.56],0.793932895434947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PGA4,Pepsin A-4,Inverse variance weighted,7,1.06 [0.69-1.62],0.793934490731836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,0.98 [0.82-1.16],0.795403393047587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CAPG,Macrophage-capping protein,Wald ratio,1,1.15 [0.41-3.22],0.796334810145343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.94 [0.6-1.47],0.796619443886407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.05 [0.71-1.55],0.799123243822397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.1 [0.53-2.25],0.800199849338712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,9,1.04 [0.78-1.37],0.800379934413796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GUCA2A,Guanylin,Inverse variance weighted,7,0.93 [0.53-1.63],0.801891299768426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.95 [0.62-1.44],0.804178668258514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,11,0.96 [0.71-1.31],0.804204924587664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.96 [0.68-1.34],0.80492301363845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.94 [0.56-1.58],0.806264042968654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.17 [0.33-4.21],0.80635089663043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.04 [0.75-1.45],0.808677331087275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.02 [0.89-1.16],0.809794164342008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.03 [0.78-1.37],0.813957449950922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.96 [0.7-1.33],0.814031247477257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.95 [0.59-1.5],0.815324036709963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GPC1,Glypican-1,Inverse variance weighted,28,1.02 [0.89-1.17],0.817612734218119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,0.96 [0.67-1.37],0.818493874617494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL19,Interleukin-19,Inverse variance weighted,10,0.98 [0.83-1.15],0.821139202469167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRTN3,Myeloblastin,Inverse variance weighted,20,0.98 [0.8-1.2],0.822131776587115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.1 [0.48-2.53],0.822544083440991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NFASC,Neurofascin,Inverse variance weighted,6,0.94 [0.54-1.62],0.822800343427838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.02 [0.85-1.23],0.82432819302733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.02 [0.84-1.24],0.825041529386305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.97 [0.72-1.3],0.825615929019008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.05 [0.66-1.69],0.82566042790239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.96 [0.7-1.33],0.826170571409042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,21,1.02 [0.87-1.19],0.826763721058538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,18,1.03 [0.81-1.31],0.827014744137573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAYN,Layilin,Inverse variance weighted,3,1.11 [0.42-2.94],0.827076219680688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,0.98 [0.81-1.19],0.828073739795865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLK4,Kallikrein-4,Inverse variance weighted,5,0.92 [0.46-1.88],0.828481191454981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FBLN2,Fibulin-2,Inverse variance weighted,6,0.94 [0.55-1.62],0.828974375510189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.04 [0.71-1.54],0.829002092887211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL10,Interleukin-10,Inverse variance weighted,4,0.96 [0.66-1.39],0.830745202793539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.05 [0.66-1.67],0.830871057834423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA3,Carbonic anhydrase 3,Inverse variance weighted,10,1.03 [0.75-1.43],0.835027999833844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.95 [0.55-1.64],0.841429342393459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.03 [0.76-1.41],0.84181584178656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.01 [0.88-1.16],0.844153276666187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.91 [0.37-2.28],0.846091715484637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,1.06 [0.58-1.93],0.846209322088027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.94 [0.53-1.7],0.847416953679262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,1.02 [0.85-1.22],0.847426488091762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.16 [0.25-5.27],0.850189050435401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GAST,Gastrin,Inverse variance weighted,9,0.95 [0.53-1.68],0.850199945669033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AFP,Alpha-fetoprotein,Inverse variance weighted,67,0.99 [0.88-1.11],0.850252214743369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.98 [0.75-1.27],0.851548564698806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,1.02 [0.83-1.26],0.85564720851966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.97 [0.73-1.3],0.859654173551562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.98 [0.81-1.2],0.862493986242275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CTRC,Chymotrypsin-C,Inverse variance weighted,28,0.99 [0.88-1.11],0.864582727023852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.05 [0.62-1.76],0.865036192414256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.99 [0.91-1.09],0.865321204259623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.02 [0.78-1.35],0.866697212204296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD99,CD99 antigen,Inverse variance weighted,4,0.96 [0.61-1.52],0.867072916987967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,0.98 [0.82-1.19],0.86845666718783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,1.03 [0.75-1.41],0.868576334607134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LEPR,Leptin receptor,Inverse variance weighted,3,0.9 [0.25-3.19],0.871224635091188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.93 [0.37-2.31],0.872567446851484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,1.03 [0.69-1.56],0.874484118562289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.98 [0.72-1.32],0.876343043200561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.07 [0.45-2.54],0.876814891444372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LMNB2,Lamin-B2,Inverse variance weighted,8,1.04 [0.65-1.65],0.877842748962728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS9,Galectin-9,Inverse variance weighted,36,1.01 [0.89-1.15],0.878299322476825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.02 [0.77-1.36],0.881650050593171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD302,CD302 antigen,Inverse variance weighted,11,0.98 [0.75-1.28],0.881891264525752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.01 [0.84-1.22],0.882677145785853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.03 [0.73-1.43],0.883235277300091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,0.99 [0.81-1.2],0.888988679676148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.03 [0.72-1.46],0.891189132546583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.96 [0.55-1.68],0.891201894372369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GIP,Gastric inhibitory polypeptide,Inverse variance weighted,9,0.98 [0.68-1.4],0.891702165052965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.97 [0.66-1.43],0.891998411380342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.01 [0.87-1.18],0.892021364839008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,23,1.01 [0.86-1.18],0.892988956822513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.02 [0.79-1.31],0.89372150874114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RGMA,Repulsive guidance molecule A,Inverse variance weighted,35,1.01 [0.88-1.16],0.89380402944855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.01 [0.91-1.12],0.894242084945921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.97 [0.63-1.49],0.894994568456295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,18,1.02 [0.74-1.42],0.895086109451726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.01 [0.91-1.12],0.895390764979701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PI3,Elafin,Inverse variance weighted,18,1.01 [0.87-1.18],0.897221390183184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MFGE8,Lactadherin,Inverse variance weighted,15,1.02 [0.76-1.36],0.898203817933013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.08 [0.32-3.68],0.900545903978525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.01 [0.9-1.13],0.902038058412244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.05 [0.5-2.19],0.903936447552271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.02 [0.72-1.46],0.903971217160405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,1.06 [0.41-2.72],0.904058772263141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.03 [0.6-1.76],0.907626994876619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DSG3,Desmoglein-3,Inverse variance weighted,27,0.99 [0.86-1.15],0.907841801792345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RSPO1,R-spondin-1,Inverse variance weighted,8,0.98 [0.72-1.34],0.908738146122746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.03 [0.61-1.74],0.911842899515371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPOCK1,Testican-1,Inverse variance weighted,26,1.01 [0.83-1.24],0.913557012326113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.01 [0.85-1.2],0.914819984632629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.02 [0.64-1.63],0.921195285899276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.03 [0.53-2.04],0.923308443492533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.96 [0.4-2.31],0.925789372584754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LGALS3,Galectin-3,Inverse variance weighted,15,0.99 [0.77-1.28],0.925835125173658,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CHGB,Secretogranin-1,Inverse variance weighted,7,0.97 [0.55-1.73],0.927104012451769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.99 [0.87-1.13],0.927710042784214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PALM2,Paralemmin-2,Inverse variance weighted,9,0.99 [0.79-1.23],0.928514646506191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.97 [0.47-2],0.92889790303174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH17,Cadherin-17,Inverse variance weighted,31,1 [0.9-1.1],0.929106206697369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.02 [0.66-1.56],0.930001434606662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,1.01 [0.88-1.16],0.930925695955275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,1 [0.93-1.07],0.932320884177117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.04 [0.37-2.93],0.933621640474342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.98 [0.66-1.46],0.934893406405977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.01 [0.87-1.16],0.93969838230439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD7,T-cell antigen CD7,Inverse variance weighted,12,1 [0.88-1.12],0.940652096276389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,1.01 [0.78-1.31],0.941141848560415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.01 [0.71-1.44],0.945348846300657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.01 [0.82-1.24],0.947310584737932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,XCL1,Lymphotactin,Inverse variance weighted,15,1.01 [0.73-1.41],0.949570887474822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.03 [0.36-2.96],0.95012087627535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,THBS4,Thrombospondin-4,Inverse variance weighted,11,1.01 [0.72-1.42],0.950418375592383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.99 [0.66-1.48],0.95089570281994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.99 [0.62-1.57],0.951528165266057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1 [0.9-1.12],0.951918447099636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRSS8,Prostasin,Inverse variance weighted,14,0.99 [0.75-1.31],0.952041438283294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,KLK11,Kallikrein-11,Inverse variance weighted,13,1.01 [0.76-1.33],0.954677941225947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1 [0.84-1.18],0.955816153237402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,THBD,Thrombomodulin,Inverse variance weighted,11,0.99 [0.78-1.27],0.956017476669905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1.01 [0.67-1.52],0.957209755370364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.99 [0.65-1.5],0.958316021792973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.01 [0.79-1.28],0.959169940826815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.98 [0.5-1.95],0.959465965826167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,1.01 [0.7-1.46],0.959542241532305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AMBP,Protein AMBP,Inverse variance weighted,5,1.01 [0.72-1.41],0.961791041368325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,HJV,Hemojuvelin,Inverse variance weighted,2,0.98 [0.38-2.52],0.962033288187971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CSTB,Cystatin-B,Inverse variance weighted,23,1 [0.9-1.12],0.962248712642503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,1 [0.9-1.11],0.962917363438553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.99 [0.64-1.52],0.963166249816316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.01 [0.73-1.39],0.964837612335644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DSC2,Desmocollin-2,Inverse variance weighted,16,1 [0.85-1.18],0.96683621637485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1 [0.79-1.26],0.967727102345535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,VWC2,Brorin,Inverse variance weighted,12,1.01 [0.7-1.44],0.968654886953519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1 [0.83-1.2],0.974071937647209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1.01 [0.57-1.78],0.974171775306709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,AGRP,Agouti-related protein,Inverse variance weighted,16,1 [0.81-1.25],0.97477638097657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.99 [0.36-2.71],0.977131727784222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,38,1 [0.84-1.18],0.979269725154935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CR2,Complement receptor type 2,Inverse variance weighted,36,1 [0.81-1.23],0.979351805478251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1 [0.82-1.21],0.982175938840059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,GOLM2,Protein GOLM2,Inverse variance weighted,14,1 [0.84-1.19],0.983967343636296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,0.99 [0.37-2.64],0.985217765554252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,LMOD1,Leiomodin-1,Inverse variance weighted,6,1 [0.74-1.34],0.985539401079702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1 [0.72-1.39],0.986127341154141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.99 [0.32-3.09],0.988154319453361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,STC2,Stanniocalcin-2,Inverse variance weighted,10,1 [0.65-1.56],0.989398566737066,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CDH3,Cadherin-3,Inverse variance weighted,10,1 [0.59-1.7],0.989821279010626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1 [0.74-1.36],0.991081017487708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CALB1,Calbindin,Inverse variance weighted,9,1 [0.7-1.43],0.991279333160857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1 [0.4-2.49],0.992941906502233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1 [0.84-1.19],0.994296163388179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,CCL11,Eotaxin,Inverse variance weighted,11,1 [0.78-1.28],0.995472668808278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1 [0.92-1.08],0.995925490067708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,XG,Glycoprotein Xg,Inverse variance weighted,2,1 [0.39-2.53],0.997521138391324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,FAM3D,Protein FAM3D,Inverse variance weighted,38,1 [0.89-1.13],0.997741086042717,trans
